跳至主要内容
临床试验/NCT07765251
NCT07765251已完成不适用

Smoking is Associated With Angiogenesis Through the Expression of FBXW7 and KLF2 in Periodontal Disease

Inonu University1 个研究点 分布在 1 个国家目标入组 114 人开始时间: 2024年3月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
114
试验地点
1
主要终点
GCF and Salivary VEGF, NF-κB, KLF2, and FBXW7 Protein Levels

研究概览

简要总结

Gum disease (gingivitis and periodontitis) is a common inflammatory condition affecting the tissues that support the teeth. Smoking is known to make gum disease worse and to affect blood vessel health in the gums. This study looks at two proteins, KLF2 and FBXW7, which are involved in blood vessel formation, to understand their role in gum disease and whether smoking changes their levels. Researchers measured these proteins, along with two other markers of inflammation and blood vessel activity (VEGF and NF-κB), in fluid collected from around the teeth and in saliva from healthy adults who were either smokers or non-smokers, with healthy gums, gingivitis, or periodontitis. The goal is to better understand how smoking and gum disease affect blood vessel-related proteins in the mouth.

详细描述

Angiogenesis, the formation of new blood vessels, is considered an early host response involved in the progression of periodontal disease. KLF2 is a transcription factor that negatively regulates angiogenesis and endothelial activation, while FBXW7 contributes to vascular development and has been reported to modulate KLF2 expression. Smoking is a major modifiable risk factor for periodontal disease and is known to affect periodontal vascularity, although the underlying molecular mechanisms remain incompletely understood. This study evaluates the potential involvement of KLF2 and FBXW7, alongside the established angiogenic and inflammatory mediators VEGF and NF-κB, in periodontal disease pathogenesis, and examines whether smoking modifies their expression in gingival crevicular fluid and saliva.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Inclusion criteria for the Healthy Control group:
  • •presence of ≥ 20 teeth in the mouth
  • •probing pocket depth (PPD) ≤ 3 mm
  • •the percentage of bleeding sites for the whole mouth < 10%,
  • •on radiographic examination, a distance of ≤ 3 mm between the cemento-enamel junction and the alveolar bone crest in 95% of all teeth.
  • •Inclusion criteria for the Gingivitis group were
  • •presence of ≥ 20 teeth in the mouth
  • •PPD ≤ 3 mm,
  • •% of bleeding sites for the whole mouth ≥ 10%,
  • •on radiographic examination, a distance of ≤ 3 mm between the cemento-enamel junction and the alveolar bone crest in 95% of all teeth.
  • •Inclusion criteria for the Stage 3 Periodontitis group
  • •presence of ≥ 15 teeth in the mouth
  • •more than 30% of teeth affected by periodontal disease
  • •affected teeth exhibiting probing depths of 6 mm or more
  • •clinical attachment loss (CAL) of ≥ 5 mm,
  • •vertical bone loss of 3 mm or more
  • •class 2 or 3 furcation involvement
  • •radiographic evidence of alveolar bone loss extending to the middle third and beyond (33%) in the relevant teeth

排除标准

  • •presence of any systemic disease
  • •regular use of any medication
  • •pregnancy or lactation
  • •periodontal treatment within the last 6 months
  • •antibiotic use within the last 6 months
  • •the presence of prosthetic restorations on the teeth to be sampled

研究组 & 干预措施

Group S-G

gingivitis and smokers

Group S-P

periodontitis and non-smokers

Group H

periodontally healthy and non smokers

Group G

gingivitis and non-smokers

Group P

periodontitis and non-smokers

Group S-H

periodontally healthy and non smokers

结局指标

主要结局

GCF and Salivary VEGF, NF-κB, KLF2, and FBXW7 Protein Levels

时间窗: March to September 2024

Total amounts and concentrations of VEGF, NF-κB, KLF2, and FBXW7 were measured by ELISA in gingival crevicular fluid (GCF) and unstimulated whole saliva samples, and compared across participants with periodontal health, gingivitis, and periodontitis, in both smokers and non-smokers.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Kubra Aral

Associate Professor

Inonu University

研究点 (1)

Loading locations...

相似试验